美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

KraneShares MSCI All China Health Care Index ETF

18.32

+0.03500.19%

成交量：1.19萬

成交額：21.83萬

市值：1.08億

市盈率：- -

高：18.43

開：18.28

低：18.20

收：18.28

52周最高：21.50

52周最低：14.38

股本：590.02萬

流通股本：590.02萬

量比：0.72

換手率：0.20%

股息：0.71

股息率：3.90%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

港股通中海油淨流入4.51億港元

阿斯达克财经

石藥集團：多巴胺受體激動劑羅替高汀長效注射液獲批臨床

石藥集團(01093)：戈舍瑞林緩釋注射液(SYH9102注射液)在中國獲臨床試驗批准

石藥集團(01093)：戈舍瑞林緩釋注射液(SYH 9102注射液)在中國獲臨床試驗批准

石藥集團戈舍瑞林緩釋注射劑（SYH9102）獲中國臨床試驗批准

《大行》滙豐研究：醫療健康行業受穩健需求支持看好信達生物(01801.HK)、科倫博泰(06990.HK)、藥明康德(02359.HK)

阿斯达克财经

《大行》里昂：中國創新藥板塊重返Alpha主導宏觀波動或提供買入機會

阿斯达克财经

《輪動華泰》國際油價企六周高位光通訊股份跟隨外圍急升

阿斯达克财经

【灣區早參】調查顯示2025年香港投資產品銷售創新高；澳門設立民航業發展工作組

石藥集團(01093.HK)：化藥創新藥SYH2083滴眼液在中國獲臨床試驗批准

【券商聚焦】招商證券維持藥明生物（02269）強烈推薦指上調指引釋放增長信號

康方生物(09926)出現大手賣出23.3萬股，成交價$96.2，涉資2.241千萬

阿斯达克财经

信達生物(01801)出現大手買入5.8萬股，成交價$100.2，涉資581.16萬

阿斯达克财经

信達生物(01801)出現大手買入6.05萬股，成交價$100.3，涉資606.815萬

阿斯达克财经

商務部新增84個全國重點外資項目

藥明生物(02269)出現大手買入12.85萬股，成交價$48.0，涉資616.8萬

阿斯达克财经

上半年創新藥冰火兩重天：百濟神州一款藥賣了超160億元，六成藥企還在求生

每日经济新闻

第4項！石藥EGFR ADC擬納入突破性療法

石藥集團(01093)：SYH2085片用於治療成人單純性流感的II期臨床試驗在中國正式啓動

一個還沒進臨床的分子，憑什麼賣出12.95億美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/KURE/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.315,"timestamp":1789751944199,"preClose":18.28,"halted":0,"volume":11931,"delay":0,"changeRate":0.0019146608315098546,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"交易中","change":0.035,"latestTime":"09-18 13:23:45 EDT","open":18.28,"high":18.4299,"low":18.2,"amount":218284.016154,"amplitude":0.012577,"askPrice":18.5,"askSize":400,"bidPrice":18.15,"bidSize":400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.28,"sharesOutstanding":4750002,"nav":18,"aum":106217991.86,"dividendRate":0.039028,"bidAskSpread":0.007567,"postHourTrading":{"tag":"盘后","latestPrice":18.28,"preClose":18.28,"latestTime":"19:30 EDT","volume":9,"amount":164.52,"timestamp":1789687803600,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.723122,"impliedVol":0.1722,"impliedVolPercentile":0.3665},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.723122,"shares":5900168,"dividePrice":0.7148,"high":18.4299,"amplitude":0.012577,"preClose":18.28,"low":18.2,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":18.315,"eps":0,"divideRate":0.039028,"volume":11931,"delay":0,"ttmEps":0,"open":18.28,"prevYearClose":17.04,"prevWeekClose":17.74,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":17.74,"twentyDayClose":19.34,"sixtyDayClose":15.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666584036","title":"港股通中海油淨流入4.51億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584036","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584036?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:25","pubTimestamp":1788949500,"startTime":"0","endTime":"0","summary":"北水南向净流入中海油及腾讯，分别达4.51亿港元及2.66亿港元。北水南向净流出智谱、建滔积层板及MINIMAX-W，分别达3.87亿港元、2.92亿港元及2.37亿港元。港股通(深)最高资金净流入活跃股份为百度集团－Ｗ17.35亿港元，而最高资金净流出股份为信达生物7.37亿港元。全日南向合计净流出0港元，总成交额为857.36亿元，占大市成交额41.83%。(港股报价延迟最少十五分钟。沽空资料截至 2026-09-09 16:25。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20211018121505815_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20211018121505815_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543686/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543686/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE0003895053.USD","LU1051768304.USD","LU0345776255.USD","SOCL","HK0000286598.CNH","EEMX","LU1655091459.SGD","LU2362541513.USD","IE00B543WZ88.USD","LU0640798160.USD","LU0918141705.HKD","LU0791591158.USD","LU1366334651.USD","LU0577902611.USD","BK1575","LU1880383440.USD","LU0823041008.USD","IE00B0169N27.USD","LU0164872284.USD","LU0823413587.USD","600938","LU1769817179.HKD","LU0359201885.HKD","BK1517","SG9999007991.SGD","IE00BQXX3D17.EUR","LU0449509016.USD","TCHI","LU0061477393.USD","FPA","LU0572939691.SGD","LU0084288322.USD","LU1718418525.SGD","LU0516422440.USD","LU0348814723.USD","LU3227948356.SGD","LU0164865239.USD","JEMA","LU0823413660.USD","LU2051468812.USD","LU0106959298.USD","LU2294711473.HKD","LU1023057109.AUD","IE00BQXX3F31.USD","LU0588545904.SGD","LU0823040885.USD","LU0348735423.USD","LU0577902538.SGD","LU1226288097.SGD","XSOE","BK1615","LU1868837722.USD","LU0786609619.USD","LU0516423174.USD","SGXZ62798434.SGD","LU1048596156.SGD","LU0328353924.USD","LU0229945570.USD","LU1251922891.USD","LU0329678337.USD","LU1725190679.HKD","LU0197773160.USD","LU0541502299.USD","LU1224709979.USD","LU0196878994.USD","LU1226287792.SGD","LU1282649141.HKD","LU0417516902.SGD","LU0608807946.USD","LU0784639295.USD","LU0384037296.USD","ESPO","LU1675838814.USD","SGXZ99366536.SGD","LU0287142896.SGD","LU1226287529.USD","LU1235295612.USD","LU1733274473.HKD","HK0000914686.HKD","LU1960683339.HKD","SGXZ51526630.SGD","LU0823039010.USD","LU2097828714.EUR","LU0143863198.USD","LU1880398554.USD","BK1609","LU0049853897.USD","LU2237443382.USD","09888","HTCD.SI","LU0880133367.SGD","BK1610","LU2187417386.USD","SG9999017495.SGD","LU2237443895.HKD","LU0414403682.SGD","LU0823397285.USD","LU0577902371.SGD","LU1917777945.USD","LU0173614495.USD","LU1328615791.USD","BK1586","SG9999001903.USD","LU0890818403.SGD","LU2279701549.SGD","LU0862451837.USD","LU0165289439.USD","LU0261950983.USD","LU0181495838.USD","LDEM","SG9999000327.SGD","BK1589","LU0455707207.USD","LU0865486749.SGD","SG9999015952.SGD","IE0003795394.USD","LU0117841782.USD","FFEM","SG9999000418.SGD","LU0651947912.USD","LU0791590937.USD","LU0211977185.USD","LU0651946864.USD","LU0708995583.HKD","LU0441854154.USD","HK0001040168.HKD","LU2362541273.HKD","LU1242518857.USD","HK0000288784.HKD","LU2488822045.USD","LU0048388663.USD","LU1720051017.SGD","LU0543330566.HKD","LU2399975544.HKD","LU2498475776.HKD","89988","HK0000914660.USD","LU1810669033.SGD","LU1688375341.USD","LU2237443465.HKD","LU2237443549.SGD","LU0737861772.HKD","LU0456827905.SGD","LU1733274390.USD","IE0032834883.USD","LU0130103400.USD","LU1196710351.USD","BK1588","LU1282649810.SGD","HK0000352382.USD","LU0348784397.USD","LU0516422366.SGD","LU0605514214.HKD","BK1149","TCHmain","80883","LU0878005551.USD","LU2045819591.USD","LU0348805143.USD","601869","IE00BZ08YS42.EUR","LU1048588211.SGD","LU2293587155.HKD","IE0034224299.USD","LU1201861165.SGD","SG9999001846.SGD","LU0543330483.HKD","LU0127658192.USD","SG9999006514.SGD","JADE","HK0000352291.HKD","LU0918141887.USD","BK1095","LU2148510915.USD","LU0589944569.HKD","LU0516423091.SGD","LU0052750758.USD","KURE","LU0648000940.SGD","LU0762540952.USD","LU1115378108.SGD","IE0008368742.USD","LU0320764755.SGD","LU0048597586.USD","LU0203345920.USD","LU0417516738.SGD","LU1188198961.HKD","SG9999002463.SGD","SG9999002828.SGD","LU0650527681.SGD","LU1152091168.USD","LU2265009873.SGD","LU1226288170.HKD","LU0499858438.USD","LU0588545490.SGD","LU1051769294.HKD","SG9999014906.USD","IE00BF5LJ272.USD","01888","LU2242644610.SGD","LU0106259558.USD","LU0314109678.HKD","LU2237443978.SGD","HK0000107257.USD","LU0149721374.USD","LU0396098781.USD","SG9999001069.SGD","LU1282649067.USD","LU1807302812.USD","LU1048484197.HKD","LU1282651121.HKD","LU0823426308.USD","LU0608807433.USD","IE00B031HY20.USD","LU0577902298.EUR","MCHS","LU2237443622.USD","IE0032431581.USD","KWEB","LU0488056044.USD","LU1734074674.USD","LU2097828631.EUR","LU0819123356.HKD","LU0531971595.HKD","LU0499858602.USD","LU0878004406.USD","BK1161","IE0003851619.USD","LU0672654166.SGD","LU0594300179.USD","GAMR","IE0009570106.USD","LU1769817096.USD","LU0648948544.HKD","BK1516","LU2929501877.USD","LU0541501648.USD","LU0203347892.USD","LU0886674414.USD","LU2106854487.HKD","BIDU","LU0516422952.EUR","ODDS","LU0862451753.SGD","LU1102505762.USD","SG9999014880.SGD","LU0871576103.HKD","LU1196710195.USD","LU1504937902.USD","SG9999004220.SGD","IE00BMPRXN33.USD","LU0456846285.SGD","LU0831103253.SGD","LU1206782309.USD","LU1481107354.HKD","LU0048580855.USD","LU0477156797.USD","LU0607220059.USD","IE0001KFT4U8.USD","LU0634319403.HKD","LU2097828805.USD","LU0359202008.SGD","BK1591","BK1523","BKF","LU0210526637.USD","LU1282651048.USD","HBBD.SI","LU0540923850.HKD","LU0431992006.USD","02513","LU1880398471.USD","00883","LU1813983027.USD","LU0106252389.USD","LU0211331839.USD","BK1528","SGXZ31699556.SGD","LU0269904917.USD","BK1587","LU0348827113.USD","LU1064131003.USD","LU2039709279.SGD","LU1956131251.USD","BIDD","BK1501","LU0244354667.USD","IE00B0169L03.USD","HK0000306685.HKD","LU0188438112.USD","LU0039217434.USD","LU1883866441.USD","LU0261947096.USD","LU1211504680.USD","LU0594300419.USD","LU0259732245.USD","SG9999001689.USD","LU1548497426.USD","LU2257852520.SGD","LU1439103000.SGD","LU2317271919.USD","LU1328277881.USD","LU1719994722.HKD","LU0370786039.SGD","LU0164880469.USD","LU0320764243.SGD","HK0001040143.USD","LU0509642566.USD","LU1785774172.SGD","BK1506","IE00B3M56506.USD","SG9999015978.USD","LU0797268264.HKD","LU1808992512.USD","LU0572940350.SGD","LU1366334578.USD","LU0633140727.USD","LU0588545730.USD","LU1568876335.HKD","LU1226287875.USD","LU0169518387.USD","LU2251237488.HKD","EMCS","LU1316542783.SGD","LU0080751232.USD","LU0348723411.USD","LU0683595622.HKD","GB00BDT5M118.USD","LU0197773673.USD","06869","LU0821914370.USD","LU2177674079.SGD","LU0149534421.HKD","LU1439102457.SGD","LU0828237940.HKD","LU0051755006.USD","LU0856984785.SGD","09988","LU0588546209.SGD","SG9999015945.SGD","BK1526","LU0762542818.HKD","BABA","BK1249","LU0345775950.USD","LU0898667661.SGD","SG9999018865.SGD","LU1196710864.SGD","LU0011963245.USD","LU0029874905.USD","SG9999013353.USD","LU0737861699.HKD","LU0329678170.USD","LU0348816934.USD","IE00BZ08YT58.USD","LU0348788117.USD","SGXZ86797644.SGD","BK1583","LU2008162690.USD","IE00B8HQ1Z84.USD","LU2247934214.USD","LU1629966141.USD","LU0348783233.USD","SG9999000459.SGD","LU0417516571.SGD","LU0163747925.USD","BK1521","LU0502904849.HKD","LU0979878070.USD","LU1171460220.USD","LU0029875118.USD","LU0289960550.SGD","LU0823426480.USD","LU1568876251.USD","LU2125910849.SGD","LU2279858448.HKD","BK1238","LU2476274308.USD","LU1868838027.USD","LU1224444064.USD","LU1323998911.USD","LU0675040207.SGD","SG9999001226.SGD","LU2351347302.SGD","IE00B031J352.USD","LU0326948709.USD","LU0320764599.SGD","LU2462611646.USD","LU0823397103.USD","LU2778985437.USD","LU0049112450.USD","LU1770036033.HKD","CXSE","IE00B067MR52.USD","LU0561508036.HKD","LU1044876610.USD","BK1608","LU2087589342.USD","LU0469268626.HKD","LU2097828474.EUR","LU2097828557.USD","LU1831875114.USD","LU1105468828.SGD","LU1242518931.SGD","LU0348783662.USD","LU0593848301.USD","LU0274383008.USD","IE0008368304.USD","LU1770034418.SGD","IE00BMPRXR70.SGD","LU1804176565.USD","LU1720051108.HKD","BK1502","LU0117844026.USD","01801","LU0359201612.USD","SG9999014898.SGD","LU0140636845.USD","LU0326950275.SGD","IE00B0JY6N72.USD","LU1794554557.SGD","LU2097829019.USD","AAXJ","LU2023250504.SGD","LU0307460666.USD","SG9999006597.SGD","LU1691799644.USD","LU0873338254.USD","LU2476274720.SGD","LU1868837565.USD","LU0327786744.USD","LU0611395673.USD","HK0000151867.HKD","LU0630378429.USD","LU1044875133.USD","LU1961090484.USD","00700","LU3063872942.SGD","LU0345769128.USD","LU2357305700.SGD","LU2328871848.SGD","LU0107464264.USD","LU0235996351.USD","SGXZ90724238.SGD","BK1117","LU0067412154.USD","LU0315179316.USD","IE00BGV7N243.SGD","IE00B97KM107.HKD","LU0070217475.USD","LU0531970944.HKD","IE00B8L5B284.USD","LU1720050803.USD","HK0000306701.USD","HK0000320264.USD","LU0175139822.USD","LU1226288253.USD","SG9999015986.USD","LU1880383366.USD","SG9999001093.SGD","LU0708995153.HKD","LU0264606111.USD","IE0008369823.USD","LU0456842615.SGD","BK1618","LU0762541174.USD","EMC","LU0642271901.SGD","LU0128522157.USD","LU0700851271.USD","LU2362540622.SGD","LU1064130708.USD","IE0031814852.USD","IE00B031HW06.USD","LU0348825331.USD","FDNI","SG9999018857.SGD","LU1515016050.SGD","LU0828238088.HKD","IE00B5MMRT66.SGD","LU0047713382.USD","LU0096374516.USD","LU0231483743.USD","TCEHY","LU0868486357.SGD","LU0738912210.USD","LU0054450605.USD","LU1102505929.USD","LU1993786604.SGD","LU0828237510.HKD","LU0449515922.USD","SG9999001051.SGD","LU1974910355.USD","LU0315178854.USD","LU0128522744.USD","LU1981816686.USD","LU0251144936.SGD","LU0072462343.USD","HK0000288743.USD","HK0000320223.HKD","LU0572944931.SGD","89888","LU0831093199.SGD","LU0463099449.HKD","LU2251237306.USD","LU1642822792.SGD","BK1170","IE00B29SXG58.USD","LU0130518102.USD","SG9999014914.USD","LU0985320562.USD","BK1142","IE00BZ08YR35.GBP","LU0228659784.USD","IE0008368411.USD","LU0228367735.SGD","BK1531","LU0214875030.USD","00100","LU0293314216.USD","LU2133065610.SGD","LU1969619763.USD","LU0501845795.SGD","LU0254981946.USD","LU0819121731.USD","LU1303224171.USD","LU1282648689.USD","LU1152091754.HKD","LU1951186391.HKD","HK0000165453.HKD","LU2152927971.USD","LU2226246903.HKD","LU0577902454.USD","BK1584","LU0143863784.USD","IE00BQXX3C00.GBP","LU0054237671.USD","LU0823038988.USD","SG9999002562.SGD","LU1814569148.SGD","LU0210527791.USD","IE00BPRC5H50.USD","LU0043850808.USD","LU1008478684.HKD","LU0132412106.USD","LU2125910500.SGD","LU2449936058.SGD","LU0072913022.USD","LU0192582467.USD","LU1044874839.SGD","SGXZ81514606.USD","LU1046422090.SGD","LU0972618739.USD","LU0210533765.USD","LU0882747503.HKD","SG9999014674.SGD","SG9999003461.SGD","LU0630378692.HKD","LU0633140560.USD","LU0345769631.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666778582","title":"石藥集團：多巴胺受體激動劑羅替高汀長效注射液獲批臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2666778582","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666778582?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:18","pubTimestamp":1788949080,"startTime":"0","endTime":"0","summary":"9月9日，石药集团（01093）发布公告，公司开发的多巴胺受体激动剂罗替高汀长效注射液（SYH9087注射液）已获国家药品监督管理局批准，可开展临床试验。公告提到，该产品为国内首个获批开展临床试验的皮下注射罗替高汀长效产品，利用本集团的长效递送技术平台，以具有良好生物相容性的辅料为基础，经皮下注射后形成原位药物贮库，从而可实现药物长效递送。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609093869445490.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609093869445490.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B543WZ88.USD","HK0000165453.HKD","LU0501845795.SGD","LU1226288170.HKD","LU1226288253.USD","LU1226287792.SGD","IE00BZ08YT58.USD","LU0326950275.SGD","IE00B031HY20.USD","LU1008478684.HKD","LU1951186391.HKD","LU1152091754.HKD","BK1191","BK1521","SG9999004220.SGD","LU0067412154.USD","IE00BZ08YS42.EUR","LU0315179316.USD","LU1993786604.SGD","IE0008369823.USD","IE00B5MMRT66.SGD","LU1807302812.USD","BK1515","IE0008368742.USD","IE00BZ08YR35.GBP","LU0140636845.USD","LU1152091168.USD","LU1960683339.HKD","LU2039709279.SGD","LU1813983027.USD","KURE","01093","LU0314109678.HKD","LU0880133367.SGD","LU1226287529.USD","LU0072913022.USD","LU1226287875.USD","LU1328277881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666846135","title":"石藥集團(01093)：戈舍瑞林緩釋注射液(SYH9102注射液)在中國獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2666846135","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666846135?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:09","pubTimestamp":1788948562,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，本集团开发的促性腺激素释放激素受体激动剂戈舍瑞林缓释注射液(该产品)已获中国国家药品监督管理局批准，可在中国开展临床试验。该产品为全球首款获批临床的即用型戈舍瑞林缓释注射液，可通过与垂体GnRH受体高亲和力结合并诱导受体降调节，抑制促性腺激素分泌，降低血清睾酮及雌二醇水平，实现药物去势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","LU2039709279.SGD","LU0314109678.HKD","LU1328277881.USD","MDTX","LU0501845795.SGD","IBBQ","IE0008368742.USD","KURE","IE00B543WZ88.USD","LU1226288170.HKD","BMED","LU0067412154.USD","LU1960683339.HKD","LU0140636845.USD","LU0326950275.SGD","IBBJ","01093","IE00BZ08YR35.GBP","IE00B031HY20.USD","IE00BZ08YT58.USD","LU0880133367.SGD","LU1226287529.USD","LU1813983027.USD","LU1951186391.HKD","PSYK","LU0315179316.USD","IE00B5MMRT66.SGD","BK1191","LU0072913022.USD","BK1515","IE0008369823.USD","LU1008478684.HKD","BK1521","LU1152091168.USD","LU1226288253.USD","LU1226287875.USD","LU1993786604.SGD","LU1152091754.HKD","LU1226287792.SGD","SG9999004220.SGD","LU1807302812.USD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584690","title":"石藥集團(01093)：戈舍瑞林緩釋注射液(SYH 9102注射液)在中國獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584690","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584690?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:08","pubTimestamp":1788948523,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 公布，该集团开发的促性腺激素释放激素受体激动剂戈舍瑞林缓释注射液已获中华人民共和国国家药品监督管理局批准，可在中国开展临床试验。该产品为全球首款获批临床的即用型戈舍瑞林缓释注射液，可通过与垂体GnRH受体高亲和力结合并诱导受体降调节，抑制促性腺激素分泌，降低血清睾酮及雌二醇水平，实现药物去势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493974.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0072913022.USD","HK0000165453.HKD","KURE","LU0140636845.USD","LU1951186391.HKD","LU1807302812.USD","IE00BZ08YR35.GBP","LU1960683339.HKD","BMED","LU1008478684.HKD","LU1226288170.HKD","IE00B5MMRT66.SGD","IBBQ","LU0315179316.USD","LU0326950275.SGD","BK1521","LU1328277881.USD","LU1152091754.HKD","IE0008368742.USD","BK1191","IE00B031HY20.USD","IE00BZ08YT58.USD","LU1813983027.USD","LU0067412154.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","BK1515","LU1152091168.USD","SG9999004220.SGD","IBBJ","01093","IE00B543WZ88.USD","LU0501845795.SGD","LU1226287875.USD","PSYK","LU1226288253.USD","MDTX","LU1226287529.USD","LU0314109678.HKD","LU1226287792.SGD","LU0880133367.SGD","IE0008369823.USD","LU1993786604.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184219055","title":"石藥集團戈舍瑞林緩釋注射劑（SYH9102）獲中國臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1184219055","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184219055?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:08","pubTimestamp":1788948506,"startTime":"0","endTime":"0","summary":"石药集团宣布，其研发的戈舍瑞林缓释注射剂已正式获得中国国家药品监督管理局的临床试验批准。石药集团此次获批的缓释剂型，旨在提供更持久的药物释放效果，有望改善患者的治疗体验和依从性。获得临床试验批准后，石药集团将按照相关法规和伦理要求，组织开展一系列临床试验，以评估该注射剂的安全性、有效性和药代动力学特性。石药集团表示，将积极推进该产品的临床研发进程，并严格遵守国家药品监管的相关规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","IE00BZ08YT58.USD","SG9999004220.SGD","LU1226288253.USD","LU1008478684.HKD","LU1226288170.HKD","LU1152091754.HKD","LU1813983027.USD","01093","LU0067412154.USD","IE00B031HY20.USD","IE0008369823.USD","LU1226287875.USD","BK1515","LU1951186391.HKD","KURE","IE00B543WZ88.USD","LU1152091168.USD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","LU2039709279.SGD","LU0326950275.SGD","LU1226287529.USD","LU1807302812.USD","LU0072913022.USD","BK1521","LU0880133367.SGD","LU1226287792.SGD","HK0000165453.HKD","LU0140636845.USD","LU1993786604.SGD","LU0315179316.USD","LU1960683339.HKD","LU1328277881.USD","LU0501845795.SGD","LU0314109678.HKD","IE0008368742.USD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666588890","title":"《大行》滙豐研究：醫療健康行業受穩健需求支持 看好信達生物(01801.HK)、科倫博泰(06990.HK)、藥明康德(02359.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666588890","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666588890?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 14:56","pubTimestamp":1788936960,"startTime":"0","endTime":"0","summary":"汇丰研究较看好信达生物、科伦博泰及药明康德，均予“买入”评级，目标价分别为130元、584元及220.5元。泰格医药管理层对2026年新订单净增长逾20%具信心，受临床试验需求增长及生物科技融资复苏带动。汇丰研究对泰格医药、英硅智能及恒瑞医药亦给予“买入”评级，目标价分别为55.4元、84.5元及73.7元。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221020153516970_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221020153516970_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543616/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543616/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0052750758.USD","LU0196878994.USD","LU2097828631.EUR","159760","HK0000165453.HKD","LU0607220059.USD","BK1583","LU1188198961.HKD","LU0502904849.HKD","LU2097828474.EUR","IE00BPRC5H50.USD","LU0456842615.SGD","LU0572944931.SGD","LU1808992512.USD","02359","LU1969619763.USD","LU0320764599.SGD","LU1997245094.SGD","LU0348766576.USD","IE00B543WZ88.USD","BK0216","LU0611395673.USD","LU2097828805.USD","LU0708995583.HKD","LU1303224171.USD","BK1161","KURE","LU2328871848.SGD","LU0700851271.USD","LU2125910500.SGD","LU1719994722.HKD","LU2495084118.USD","03441","LU1997244956.HKD","LU1934453819.USD","06990","BK1589","BK1141","LU2097828557.USD","LU0463099449.HKD","LU1251922891.USD","LU2045819591.USD","LU1770034418.SGD","LU0244354667.USD","LU0326950275.SGD","603259","LU1046422090.SGD","LU0455707207.USD","01801","LU0469268626.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666304134","title":"《大行》里昂：中國創新藥板塊重返Alpha主導  宏觀波動或提供買入機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2666304134","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666304134?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 12:08","pubTimestamp":1788926880,"startTime":"0","endTime":"0","summary":"里昂发表报告指，中国创新药板块正重回以公司基本面与个股超额收益为主导的市场，公司特定基本面相对宏观因素的影响力回升。该行预期，随市场对创新药企临床及BD执行信心改善，基本面角色将愈趋重要；短期宏观波动或提供趁低买入、验证此观点的机会。该行认为，重大临床读出与BD活动加速，正面催化剂窗口正在打开。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220210100852532_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220210100852532_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543577/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543577/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01801","LU0140636845.USD","IE00B031HY20.USD","BK0226","IE00BZ08YR35.GBP","LU1328615791.USD","LU2125910500.SGD","LU0149534421.HKD","LU0348825331.USD","LU2045819591.USD","LU1655091616.SGD","LU0417516738.SGD","SG9999004311.SGD","LU1794554557.SGD","02359","LU1580142542.USD","603259","LU2097828714.EUR","LU0469268626.HKD","IE00B5MMRT66.SGD","LU1226287875.USD","LU1226287792.SGD","LU2476274308.USD","600276","LU0640798160.USD","SHTDY","LU1226288253.USD","02162","LU0607220059.USD","LU1997244956.HKD","LU2039709279.SGD","LU2097828474.EUR","LU2778985437.USD","BK1574","300765","BK0239","LU1997245094.SGD","LU2495084118.USD","LU1008478684.HKD","BK1161","LU2399975544.HKD","LU0244354667.USD","BK1500","LU0572944931.SGD","BK1197","LU1226287529.USD","LU1720050803.USD","BK1515","IE00BVYPNP33.GBP","IE00BPRC5H50.USD","LU0348827113.USD","LU1961090484.USD","LU2097828631.EUR","LU0708995583.HKD","LU1807302812.USD","IE0008369823.USD","LU2289578879.USD","LU0540923850.HKD","SG9999015945.SGD","LU2476274720.SGD","LU2148510915.USD","LU0463099449.HKD","01276","03692","LU0348784397.USD","LU1820825898.SGD","LU0326950275.SGD","SG9999015986.USD","IE00BYV24P56.USD","LU0348766576.USD","LU2488822045.USD","LU1813983027.USD","BK1191","BK0188","LU0320764599.SGD","BK0185","LU1951186391.HKD","LU1188198961.HKD","BK0209","BK0196","LU1064131003.USD","LU1226288170.HKD","LU1781817850.SGD","BK0012","BK1141","LU1064130708.USD","BK0060","LU0067412154.USD","LU0348783233.USD","LU1997245177.USD","LU0417516902.SGD","LU1831875114.USD","LU1993786604.SGD","LU0315179316.USD","LU0502904849.HKD","LU0348735423.USD","BK0114","IE00BGHQDM52.EUR","BK0183","BK1576","IE00BMCWC346.EUR","LU0405327148.USD","LU2097828557.USD","SBHMY","LU0052750758.USD","LU2580892789.USD","BK1589","IE0008368742.USD","LU2580892862.HKD","LU1969619763.USD","603233","BK1593","LU0327786744.USD","LU1960683339.HKD","SG9999015952.SGD","01177","00867","LU2328871848.SGD","IE00B543WZ88.USD","BK1521","SG9999004220.SGD","IE00BZ08YT58.USD","IE00BVYPNQ40.USD","01093","02595","LU0417516571.SGD","01099","LU0072913022.USD","LU1255011170.USD","BK1583","LU2242644610.SGD","LU1146622755.USD","LU1152091754.HKD","LU0405327494.USD","LU0634319403.HKD","LU1115378108.SGD","KURE","BK0028","HK0000165453.HKD","BK1587","09926","LU0314109678.HKD","LU0880133367.SGD","LU1046422090.SGD","LU2097828805.USD","LU1152091168.USD","LU0561508036.HKD","LU0348767384.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","LU1328277881.USD","SG9999015978.USD","LU0455707207.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666386301","title":"《輪動華泰》國際油價企六周高位  光通訊股份跟隨外圍急升","url":"https://stock-news.laohu8.com/highlight/detail?id=2666386301","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666386301?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 10:54","pubTimestamp":1788922440,"startTime":"0","endTime":"0","summary":"------ 华泰国际轮证是日焦点 ------光通讯股份跟随外围急升油价高企“三桶油”昨齐升4%苹果发布会前部署苹概股------------------------------------------昨夜美股因油价急升及通胀担忧普遍收跌，道指重挫逾1%，惟费城半导体指数逆市升1.3%，光通讯股更大幅爆发。光通讯股份今早跟随外围大幅造好，长飞光纤升11%、中际旭创升5%。结构性产品价格可升亦可跌，持有人可能会损失全部投资。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260806133034007_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260806133034007_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543528/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543528/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["EMC","LU1051769294.HKD","LU1044874839.SGD","ODDS","LU1242518931.SGD","BKF","LU0106259558.USD","TCHmain","LU0165289439.USD","00700","LU0608807433.USD","KURE","AAXJ","EEMX","LU1105468828.SGD","LU0572939691.SGD","SG9999014880.SGD","BIDD","LDEM","LU0047713382.USD","FDNI","IE00B067MR52.USD","KWEB","LU0192582467.USD","ESPO","TCHI","SOCL","LU0181495838.USD","01801","LU0061477393.USD","LU0293314216.USD","LU0683595622.HKD","TCEHY","HTCD.SI","XSOE","LU1804176565.USD","CXSE","JADE","LU0328353924.USD","LU0348783662.USD","LU0516422366.SGD","LU0823413660.USD","LU0823426480.USD","GAMR","EMCS","JEMA","LU1226287792.SGD","LU1770034418.SGD","LU0456827905.SGD","FFEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666305412","title":"【灣區早參】調查顯示2025年香港投資產品銷售創新高；澳門設立民航業發展工作組","url":"https://stock-news.laohu8.com/highlight/detail?id=2666305412","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666305412?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 08:58","pubTimestamp":1788915491,"startTime":"0","endTime":"0","summary":"调查显示，参与客户及公司的数目均创新高，推动总交易额强劲增长。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991084","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1951186391.HKD","LU1366334578.USD","LU0128525689.USD","BK1109","BK1558","00992","LU0049112450.USD","80992","LU0890818403.SGD","HK0000320264.USD","LU0264606111.USD","KURE","LU0531970944.HKD","TCHI","LU0315179316.USD","HK0000306701.USD","BK1607","LU0310800965.SGD","IE0008368742.USD","LU0791590937.USD","LU0052756011.USD","LU0449515922.USD","01177","LU0862451753.SGD","LU0067412154.USD","LU0823040885.USD","01093","BK1526","IE00BZ08YT58.USD","LU0880133367.SGD","LU1046422090.SGD","BK1594","IE00B0JY6N72.USD","HK0000252160.HKD","BK1521","HK0000500386.USD","IE00B543WZ88.USD","IE0032431581.USD","IE00B5MMRT66.SGD","LU0048580855.USD","LU0326950275.SGD","LNVGY","HK0000306685.HKD","LU1993786604.SGD","00916","LU0862451837.USD","LU0214875030.USD","LU0072913022.USD","01745","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665296783","title":"石藥集團(01093.HK)：化藥創新藥SYH2083滴眼液在中國獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665296783","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665296783?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:48","pubTimestamp":1788860890,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0140636845.USD","IE00B031HY20.USD","LU0072913022.USD","LU1813983027.USD","BK1191","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1951186391.HKD","BK1161","LU1226288170.HKD","LU1152091754.HKD","LU1226287529.USD","LU0067412154.USD","BK1515","KURE","06978","HK0000165453.HKD","LU0315179316.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","LU0314109678.HKD","LU0880133367.SGD","LU1226287875.USD","LU1226287792.SGD","IE0008368742.USD","LU1807302812.USD","IE0008369823.USD","LU1960683339.HKD","LU1226288253.USD","LU1152091168.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","LU1328277881.USD","IE00B543WZ88.USD","BK1521","LU2039709279.SGD","SG9999004220.SGD","IE00BZ08YT58.USD","LU0326950275.SGD","BK1574","01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665731326","title":"【券商聚焦】招商證券維持藥明生物（02269）強烈推薦 指上調指引釋放增長信號","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731326","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665731326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:28","pubTimestamp":1788859690,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招商证券发布研报指，药明生物 上调2026年全年收入指引，释放明确增长信号，M端提速有望带动盈利持续改善，成长确定性突出。订单方面，截至6月末未完成订单251亿美元，同比增长23%；三年内未完成订单55亿美元，同比增长30%。招商证券预计公司2026-2028年实现收入约254、306、385亿元，经调整归母净利润72、90、115亿元，对应经调整PE分别为24、19、15倍，维持“强烈推荐”评级。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991056","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","LU0708995583.HKD","LU0456827905.SGD","LU0043850808.USD","LU1880383366.USD","LU0051755006.USD","LU1794554557.SGD","SG9999002463.SGD","BK1521","LU0456846285.SGD","LU0052750758.USD","KURE","06099","SG9999002562.SGD","LU0359202008.SGD","LU2039709279.SGD","LU0327786744.USD","LU0516423091.SGD","LU1242518931.SGD","LU0819121731.USD","LU0856984785.SGD","LU0823426480.USD","LU0348735423.USD","LU1242518857.USD","LU0140636845.USD","LU0307460666.USD","BK1610","LU0348825331.USD","BK1147","LU0516423174.USD","LU0823426308.USD","02269","LU0572944931.SGD","BK1576","LU0516422366.SGD","BK1564","LU0516422440.USD","LU1688375341.USD","BK1589","LU0417516902.SGD","LU1720050803.USD","LU0417516738.SGD","LU0979878070.USD","LU0039217434.USD","LU0320764599.SGD","LU0516422952.EUR","KCE","LU3063872942.SGD","LU0359201612.USD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665853325","title":"康方生物(09926)出現大手賣出23.3萬股，成交價$96.2，涉資2.241千萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2665853325","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665853325?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:08","pubTimestamp":1788854880,"startTime":"0","endTime":"0","summary":"[大手成交]康方生物(09926)在下午04:08出现大手卖出，成交量为23.3万，成交价为港币$96.2，涉资2.241千万。至目前为止，股价升0.208%，今日最高价为$97.3，而最低价为$94.75，总成交量为574.038万股，总成交金额港币$5.509亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609086589/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609086589/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["IE00B5MMRT66.SGD","LU0348827113.USD","LU2476274308.USD","LU0348766576.USD","LU0417516738.SGD","LU0348735423.USD","IE00B543WZ88.USD","LU2399975544.HKD","LU0348784397.USD","LU1961090484.USD","LU0417516902.SGD","LU0348767384.USD","IE00BPRC5H50.USD","LU0348825331.USD","LU0348783233.USD","BK1161","BK1574","LU0540923850.HKD","LU2778985437.USD","LU1720050803.USD","09926","LU1794554557.SGD","LU2476274720.SGD","LU2488822045.USD","KURE","LU0634319403.HKD","LU0417516571.SGD","LU0561508036.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665734211","title":"信達生物(01801)出現大手買入5.8萬股，成交價$100.2，涉資581.16萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2665734211","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665734211?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:34","pubTimestamp":1788845640,"startTime":"0","endTime":"0","summary":"[大手成交]信达生物(01801)在下午01:34出现大手买入，成交量为5.8万，成交价为港币$100.2，涉资581.16万。至目前为止，股价跌1.185%，今日最高价为$100.9，而最低价为$98.1，总成交量为481.713万股，总成交金额港币$4.799亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609085550/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609085550/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2097828631.EUR","BK1589","HK0000165453.HKD","LU2097828714.EUR","LU0326950275.SGD","LU0455707207.USD","LU2328871848.SGD","LU2097828474.EUR","LU0502904849.HKD","LU0463099449.HKD","BK1161","LU2097828805.USD","LU1969619763.USD","BK1583","01801","LU2488822045.USD","LU1188198961.HKD","LU2242644610.SGD","LU2097828557.USD","LU0244354667.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665112342","title":"信達生物(01801)出現大手買入6.05萬股，成交價$100.3，涉資606.815萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2665112342","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665112342?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:34","pubTimestamp":1788845640,"startTime":"0","endTime":"0","summary":"[大手成交]信达生物(01801)在下午01:34出现大手买入，成交量为6.05万，成交价为港币$100.3，涉资606.815万。至目前为止，股价跌1.185%，今日最高价为$100.9，而最低价为$98.1，总成交量为481.963万股，总成交金额港币$4.801亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609085551/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609085551/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0463099449.HKD","HK0000165453.HKD","LU1188198961.HKD","LU2097828557.USD","LU0502904849.HKD","BK1589","LU2328871848.SGD","KURE","LU2488822045.USD","LU2097828805.USD","LU2242644610.SGD","BK1161","BK1583","LU0326950275.SGD","LU2097828474.EUR","01801","LU0455707207.USD","LU2097828631.EUR","LU1969619763.USD","LU0244354667.USD","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665341019","title":"商務部新增84個全國重點外資項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2665341019","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665341019?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 12:05","pubTimestamp":1788840300,"startTime":"0","endTime":"0","summary":"【大河财立方记者程帅星厦门报道】9月8日，大河财立方记者在第二十六届中国国际投资贸易洽谈会(以下简称“投洽会”)上获悉，商务部近日新增84个全国重点外资项目，其中包括6个外资标志性项 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260908/c679692496.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260908/c679692496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["SG9999013999.USD","LU2237443382.USD","LU0158827948.USD","LU2237443895.HKD","LU0345770993.USD","LU0820561909.HKD","LU1551013425.SGD","ELIS","LU0964807845.USD","LU2746668461.USD","BK1141","SG9999014906.USD","LU1868836757.USD","LU2265009873.SGD","LU2087625088.SGD","IE00BKDWB100.SGD","LU2471134523.USD","LU0266013472.USD","LU0158827781.USD","LU0039217434.USD","LU2491050154.USD","LU2237443465.HKD","LU2896262040.SGD","LU1868837300.USD","GDOC","LU2328871848.SGD","LU0456827905.SGD","LU1880383366.USD","BK4534","LU1917777945.USD","LU0061475181.USD","IE00B7KXQ091.USD","VHT","LU2461242641.AUD","LU0385154629.USD","LU2023250330.USD","SKDD","FHLC","IE00B0JY6N72.USD","LU0432979614.USD","LU0052750758.USD","LU0133085943.USD","LU0289739699.SGD","LU0353189763.USD","THNR","LU2602419157.SGD","SG9999018857.SGD","BK4588","LU0823397103.USD","LU1974910355.USD","LU2213496289.HKD","LU0359201612.USD","LU1023059063.AUD","SG9999015986.USD","LU0079474960.USD","LU0820561818.USD","LU0256863811.USD","LU3063872942.SGD","IYH","LU2756315664.SGD","SG9999015978.USD","SG9999014880.SGD","LU0109394709.USD","LU0786609619.USD","LU0471298694.HKD","IE00BJJMRZ35.SGD","LU2237443978.SGD","SGXZ81514606.USD","LU2039709279.SGD","SGXZ57979304.SGD","LU2417539215.USD","LU2063271972.USD","SKHYV","LU0471298777.SGD","LU0823426480.USD","LU0174119429.USD","LLYX","SGXZ51526630.SGD","CANC","HRTS","AZN","LU2756315318.SGD","LU2468319806.SGD","LU2361044865.SGD","IE00BK4W5M84.HKD","LU2360106947.USD","LU0097036916.USD","LU0516423091.SGD","SKHZ","LU2168563687.JPY","LU0320764599.SGD","SG9999014898.SGD","LU1145028129.USD","LU1267930730.SGD","LU2168564495.EUR","LU1323610961.USD","BK1576","LU0128526141.USD","IE00BK4W5L77.USD","LU0823413587.USD","LU1093756168.USD","SK","LU2746668974.SGD","LU0787776722.HKD","LU1983299246.USD","LU2168564065.EUR","LU0348825331.USD","LU0128525929.USD","LU0029864427.USD","SGXZ99366536.SGD","BK0188","BK0028","LU0820562030.AUD","LU2237443622.USD","LU0114720955.EUR","WDNA","LU0889565916.HKD","ILDR","LU1794554557.SGD","AZNH","BK4585","LLII","LU1688375341.USD","SKHU","PJP","LU0210536198.USD","LU1551013342.USD","LU1988902786.USD","LU0417517546.SGD","LU0516422440.USD","LU0198837287.USD","LU1242518857.USD","LU0943347566.SGD","LLY","LU0096364046.USD","02269","IE0004445015.USD","002493","LU2106854487.HKD","IE00BJLML261.HKD","LU0327786744.USD","LU2552382058.USD","SG9999001176.USD","LU0316494557.USD","LU0882574139.USD","LU0320765059.SGD","IE00B2B36J28.USD","IE00BFSS7M15.SGD","LU1720051108.HKD","LU0310800379.SGD","ABB","LU2112291526.USD","LU0225283273.USD","SKHL","LU0823434583.USD","LU0359202008.SGD","LU1956131251.USD","SG9999017495.SGD","LU0882574055.USD","LU2491050071.SGD","LU1548497426.USD","SKHQ","LU0106261372.USD","LU1989771016.USD","LU2108987350.USD","LU0819121731.USD","LU1868836591.USD","LU2552382215.SGD","LU0456855351.SGD","LU2023251221.USD","MEDX","LU2028103732.USD","GB00BDT5M118.USD","LU2357305700.SGD","BK0197","BK4568","IE00BFTCPJ56.SGD","LU1720051017.SGD","IE00B3T34201.USD","LU0456846285.SGD","LU1623119135.USD","IHE","IE00BJJMRY28.SGD","LU2471134952.CNY","LU0708995401.HKD","LU0203202063.USD","BK1589","LU1035775433.USD","LU2236285917.USD","LU2168564222.USD","BK4007","FTXH","LU0823397285.USD","LU0354030511.USD","LU2471134796.USD","IXJ","07709","LU2462591350.SGD","LU0823434740.USD","LU2271345857.HKD","IE00BWXC8680.SGD","IE0004445239.USD","IE00B775H168.HKD","IE00BKPKM429.USD","LU0094547139.USD","LU2491049909.HKD","LU0353189680.USD","LU0029874061.USD","LU2471134879.HKD","LU1093756325.SGD","LU2361044949.HKD","LU2168564149.EUR","LU1969619763.USD","SG9999015952.SGD","WXXWY","SG9999002562.SGD","IE00BFSS8Q28.SGD","LU1267930573.SGD","LU0058720904.USD","LU1629891620.HKD","LU1691799644.USD","LU0823426308.USD","SG9999001176.SGD","LU0203201768.USD","IE0005OL40V9.USD","SG9999002463.SGD","LU1064131342.USD","IE00B1BXHZ80.USD","SG9999015945.SGD","ELIL","IE00BJJMRX11.SGD","LU2456880835.USD","BK4581","LU2111349929.HKD","LU1366192091.USD","BK1610","IE0009355771.USD","LU0823413660.USD","LU0516422366.SGD","LU1242518931.SGD","LU0708994859.HKD","LU0683600562.USD","BK4599","LU0823416689.USD","LU2750360641.GBP","LU0640476718.USD","LU2552382132.HKD","LU0672654240.SGD","BK4141","LU0345770308.USD","LU0323591593.USD","LU0466842654.USD","LU2089984988.USD","BK4533","LU2023250504.SGD","LU2361045086.USD","LU1804176565.USD","MEDI","LU0516422952.EUR","LU1232071149.USD","LU1720050803.USD","LU0708995583.HKD","SG9999014914.USD","PPH","LU0109391861.USD","LU0043850808.USD","LU1814569148.SGD","TRUH","LU1979441026.SGD","LU1712237335.SGD","BK0208","BK1521","SKHY","BK4516","LU1280957306.USD","LU2750360997.AUD","LU0516423174.USD","LU1069344957.HKD","BK4096","IE00B4R5TH58.HKD","SKUU","LU0122379950.USD","RXL","LU0307460666.USD","IE00BJT1NW94.SGD","LU2462157665.USD","LU0354030438.USD","LU0006306889.USD","LU2089283258.USD","IE0001KFT4U8.USD","LU1868836914.USD","SKHA","LU0979878070.USD","LU0140636845.USD","IE00B1XK9C88.USD","LU0572944931.SGD","LU0689472784.USD","BK0187","LU0348735423.USD","CURE","LU2237438978.USD","LU0417516902.SGD","LU1829250122.USD","SKHX","LU2211815571.USD","LU1061106388.HKD","TMED","AGNG","IE0002141913.USD","LU1127390331.HKD","SG9999018865.SGD","IE00BN29S564.USD","OZEM","LU0256863902.USD","LU0856984785.SGD","LU2264538146.SGD","LU0326950275.SGD","LU2324357040.USD","LU0181495838.USD","SKHN","LLYZ","IE00B4JS1V06.HKD","XLV","LU0234572021.USD","LU0320765992.SGD","LU0051755006.USD","LU0588546209.SGD","HYNX","LU2237443549.SGD","LU0417516738.SGD","LU2089284900.SGD","SGXZ31699556.SGD","MHIP","JDOC","LU1291159041.SGD","KURE","LU1057294990.SGD","LU1868837136.USD","BK0196","LU0238689110.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665834964","title":"藥明生物(02269)出現大手買入12.85萬股，成交價$48.0，涉資616.8萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2665834964","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665834964?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 10:20","pubTimestamp":1788834000,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在上午10:20出现大手买入，成交量为12.85万，成交价为港币$48.0，涉资616.8万。至目前为止，股价跌1.031%，今日最高价为$48.64，而最低价为$47.78，总成交量为512.846万股，总成交金额港币$2.473亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609084651/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609084651/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1880383366.USD","02269","BK1610","BK1141","LU0456827905.SGD","LU0456846285.SGD","LU0516423174.USD","LU0516423091.SGD","LU1720050803.USD","LU1242518931.SGD","LU0359201612.USD","BK1521","LU1688375341.USD","LU0039217434.USD","KURE","LU0516422440.USD","LU0417516902.SGD","LU0417516738.SGD","LU2039709279.SGD","LU0307460666.USD","BK1589","LU0359202008.SGD","LU0128526141.USD","LU0348825331.USD","LU0708995583.HKD","BK1576","LU0588546209.SGD","LU0819121731.USD","LU0516422952.EUR","LU0572944931.SGD","SG9999002562.SGD","LU0823426480.USD","LU0052750758.USD","SG9999002463.SGD","LU0140636845.USD","LU1242518857.USD","LU0320764599.SGD","LU0348735423.USD","LU0516422366.SGD","LU0029874061.USD","LU0823426308.USD","LU0979878070.USD","LU0326950275.SGD","LU1794554557.SGD","LU0856984785.SGD","IE00B0JY6N72.USD","LU0043850808.USD","LU0327786744.USD","LU3063872942.SGD","LU0181495838.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311078","title":"上半年創新藥冰火兩重天：百濟神州一款藥賣了超160億元，六成藥企還在求生","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311078","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311078?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:39","pubTimestamp":1788784781,"startTime":"0","endTime":"0","summary":"2026年上半年财报季收官，中国创新药产业交出了一份分水岭式的答卷。行业正在告别“烧钱讲故事”的阶段，走向“赚钱才是硬道理”的价值兑现期。这种转变并非行业普遍现象，而是由商业化放量、出海授权爆发、资金来源多元化三重力量共同推动的分化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866904351.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866904351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06160","LNGR","ONC","LU2328871848.SGD","LU1770034418.SGD","KURE","BK1574","LU1251922891.USD","LU0228659784.USD","LU1303224171.USD","BK1500","LU0588546209.SGD","LU0307460666.USD","06978","IBBQ","BK1583","BK1161","LU0828237510.HKD","BK1588","MEDX","BK4585","159992","BK0239","BK4139","BK4588","LU1719994722.HKD","688235","LU1969619763.USD","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131464","title":"第4項！石藥EGFR ADC擬納入突破性療法","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131464","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131464?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:24","pubTimestamp":1788783840,"startTime":"0","endTime":"0","summary":"9月7日，CDE官网显示，石药集团的SYS6010拟纳入突破性疗法，用于免疫及含铂化疗治疗失败的复发或转移性驱动基因阴性非鳞非小细胞肺癌。SYS6010为石药创新制药旗下子公司巨石生物开发的一款EGFR ADC，由人源化抗EGFR单克隆抗体通过可裂解连接子与拓扑异构酶I抑制剂载荷偶联而成。2026年8月，SYS6010治疗EGFR-TKI治疗失败的EGFR突变型局部晚期或转移性NSCLC的III期研究达到主要终点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-07/doc-iniqzhfq9563252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1152091754.HKD","KURE","LU1226288253.USD","LU0067412154.USD","BK1521","LU1951186391.HKD","LU1226287529.USD","IE00BZ08YS42.EUR","LU1813983027.USD","IE00BZ08YT58.USD","LU1152091168.USD","IE00B543WZ88.USD","LU1226287792.SGD","LU1226288170.HKD","LU1960683339.HKD","IE0008368742.USD","IE0008369823.USD","LU0072913022.USD","LU0140636845.USD","IE00BZ08YR35.GBP","LU0326950275.SGD","IE00B031HY20.USD","LU1008478684.HKD","LU0501845795.SGD","BK1191","BK1515","LU0315179316.USD","LU0880133367.SGD","LU2039709279.SGD","LU1328277881.USD","01093","LU1226287875.USD","SG9999004220.SGD","HK0000165453.HKD","LU1993786604.SGD","LU1807302812.USD","LU0314109678.HKD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319978","title":"石藥集團(01093)：SYH2085片用於治療成人單純性流感的II期臨床試驗在中國正式啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319978","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319978?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:30","pubTimestamp":1788780616,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的SYH2085片用于治疗成人无并发症的单纯性流行性感冒的II期临床试验已于中国首家中心正式启动。此前，集团已于2025年12月获中国国家药品监督管理局就该产品签发的《药物临床试验批准通知书》。本次启动的该产品临床试验为多中心、随机、双盲、安慰剂对照的II期临床研究，旨在评价该产品治疗中国成人无并发症的单纯性流行性感冒参与者中的有效性及安全性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0315179316.USD","LU0140636845.USD","LU1807302812.USD","LU0880133367.SGD","LU0067412154.USD","IE00B031HY20.USD","LU1993786604.SGD","01093","LU1328277881.USD","PSYK","IE0008368742.USD","LU1951186391.HKD","IE00BZ08YT58.USD","MDTX","LU0326950275.SGD","IE00B5MMRT66.SGD","IBBJ","BK1521","BK1191","BMED","LU0314109678.HKD","IE0008369823.USD","SG9999004220.SGD","LU1226287875.USD","IE00B543WZ88.USD","HK0000165453.HKD","LU1226288253.USD","BK1515","LU2039709279.SGD","IBBQ","IE00BZ08YR35.GBP","LU0072913022.USD","LU1226287529.USD","LU1008478684.HKD","LU1152091168.USD","LU1960683339.HKD","LU0501845795.SGD","LU1152091754.HKD","IE00BZ08YS42.EUR","KURE","LU1226288170.HKD","LU1813983027.USD","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665062393","title":"一個還沒進臨床的分子，憑什麼賣出12.95億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665062393","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665062393?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:08","pubTimestamp":1788746914,"startTime":"0","endTime":"0","summary":"对一款尚未进入人体临床试验的资产而言，1.1亿美元的首付款属于明显偏高的定价。2023年，和黄医药将已在中国获批上市的呋喹替尼授权给武田制药：总额11.3亿美元，首付款4亿美元。那是\"成熟产品出海\"的典范，一个经过临床验证、获批上市的分子，换取全球市场权益。HMPL-A830尚未启动I期临床，和黄医药卖的是一个\"概念验证前\"的平台资产，而12.95亿美元的总交易额，已经超过了呋喹替尼的11.3亿美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788491648644278418","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4231","BK4080","KURE","BK1191","00013","BK1587","BK1588","ADC","NETL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}